Group 1 - The company announced a share award plan adopted at the annual general meeting held on May 30, 2025 [1] - A total of 9.915 million shares will be granted to 197 eligible participants, including directors and employees of the group [1] - The grant of shares is subject to acceptance by the participants [1]

Group 1 - The core point of the article is that China Xuyang Group has announced a share award plan to grant a total of 9.915 million shares to 197 eligible participants, including directors and employees, as part of its strategy to attract, retain, and incentivize talent [1] - The share award plan was adopted during the company's annual general meeting held on May 30, 2025 [1] - The purpose of granting these shares is to encourage participants to enhance the value of the company and its shares for the benefit of the company and its shareholders [1]

Core Viewpoint - The company has adopted a share award plan effective September 1, 2025, which does not require shareholder approval as it involves existing shares only [1]. Group 1 - The share award plan is in accordance with Listing Rule 17.01(1)(b) and is classified under Chapter 17 of the Listing Rules [1]. - The plan will be funded by existing shares, thus it does not involve the issuance of new shares as per Listing Rule 17.01(1)(a) [1]. - The company must comply with the disclosure requirements under Listing Rule 17.12 related to this plan [1].

Core Viewpoint - China Liansu (02128) announced the termination of its share incentive plan due to the expectation of not granting shares before the plan's expiration and to reduce administrative costs [1] Summary by Relevant Sections - **Incentive Plan Status** - No shares have been granted under the incentive plan since its adoption [1] - The board has decided to terminate the plan effective August 31, 2025 [1] - **Impact of Termination** - The termination will not affect any existing rights of selected participants as there are currently no selected participants [1] - The board believes that the termination will not have any significant adverse impact on the company and is in the best interest of the company and its shareholders [1]

Core Viewpoint - Yunfeng Financial (00376) announced the proposal to adopt a new share award plan for 2025, which will replace the existing 2016 share award plan set to expire in December 2026, pending shareholder approval [1] Group 1: 2025 Share Award Plan - The 2025 Share Award Plan is designed to encourage eligible participants, including employees and service providers, to hold shares and align their interests with those of shareholders [1] - The plan aims to retain key contributors to the group and provide additional rewards for achieving performance targets, thereby enhancing the company's value [1] Group 2: Amendments to Existing Plans - The board proposes to amend the 2022 Share Option Plan to comply with revised listing rules, allowing the use of the company's treasury shares for option settlements [1] - The amendments will also reflect internal management adjustments and other corresponding revisions [1]

Core Viewpoint - Yunfeng Financial (00376) announced the proposal to adopt a new share award plan for 2025, which will replace the existing 2016 share award plan set to expire in December 2026, pending shareholder approval [1] Group 1: Share Award Plans - The 2025 Share Award Plan is designed to encourage eligible participants, including employees and service providers, to hold shares and align their interests with those of shareholders [1] - The board also proposed amendments to the 2022 Share Option Plan to ensure compliance with revised listing rules, allowing the use of the company's treasury shares for option settlements [1]

Group 1 - The company, Tengsheng Bo Pharmaceutical-B (02137), announced the issuance and allocation of 130,800 shares to employees as part of its restricted share unit plan adopted on June 22, 2021 [1]

Group 1 - Company announced the purchase of a total of 200,000 shares on the market as of August 21, 2025 [1] - The shares are held in trust for the benefit of selected participants according to plan rules and trust deed [1]

Core Viewpoint - The company believes its current stock price is significantly undervalued compared to its performance and intrinsic value, presenting a good opportunity for share repurchase under the share award plan [1] Group 1: Share Repurchase - The trustee has purchased a total of 200,000 shares in the market as part of the share award plan [1] - The shares are held in trust for the benefit of selected participants [1] - The company will continue to monitor market conditions and its trading stock price, instructing the trustee to make further purchases when appropriate [1] Group 2: Business Outlook - The board expresses confidence in the company's business prospects and outlook [1]

Group 1 - The company announced that it will grant 23.936 million shares as part of its employee incentive plan on August 14, 2025, pending acceptance by the recipients [1] - The awarded shares represent approximately 0.261% of the total issued shares as of the announcement date [1]